logo
Plus   Neg
Share
Email

GenVec Names Cynthia Collins President, CEO - Quick Facts

GenVec, Inc. (GNVC) said it appointed Cynthia Collins as president and chief executive officer, or CEO, effective May 23, 2012. Besides, Collins is expected to be appointed to the Board of Directors of GenVec.

Effective upon Collins' appointment, Paul Fischer will step down as GenVec's president and CEO and as a member of the Board.

Collins formerly served as Group vice president, Cellular Analysis Business of Beckman Coulter from 2007 to until its sale in 2011. Before joining Beckman Coulter, she served as CEO of Sequoia Pharmaceuticals, Inc., a private biotechnology company developing antiviral drugs. Before that, she served as president of Clinical Micro Sensors, Inc., a wholly owned subsidiary of Motorola where she directed the development and commercialization of molecular diagnostic microarray products and led the eventual strategic divestiture of the division.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Each year, more than eight million children die from preventable diseases in countries with the worst health care systems . Kofi Annan, former head of the UN, said that, "Almost all these deaths will happen in developing countries. A large number of them could be prevented." You do not want to find... As Canada prepares to legalize marijuana nationwide later this year, a national survey by Statistics Canada has thrown up some interesting facts - including that legal marijuana is not a temptation for most Canadians. Regardless of cannabis use, 79 percent of Canadians surveyed said they would not be more likely to try or increase their cannabis consumption just because it is legalized. The Procter & Gamble Company (PG) reported third-quarter net earnings per share of $0.95, an increase of two percent versus the prior year. Net earnings from continuing operations declined 1% year-over-year to $2.54 billion. Core earnings per share increased four percent to $1.00. On average, 20 analysts...
Follow RTT